Literature DB >> 33238332

The Association of Overt and Subclinical Hyperthyroidism with the Risk of Cardiovascular Events and Cardiovascular Mortality: Meta-Analysis and Systematic Review of Cohort Studies.

Seo Young Sohn1, Eunyoung Lee2, Min Kyung Lee1, Jae Hyuk Lee1.   

Abstract

BACKGROUND: Whether hyperthyroidism is an independent risk factor for cardiovascular events remains controversial. We aimed to evaluate the association of overt and subclinical hyperthyroidism with the risk of ischemic heart disease (IHD), stroke, heart failure, and cardiovascular mortality.
METHODS: Studies regarding the association between hyperthyroidism and cardiovascular events were searched on PubMed and Embase databases. The cardiovascular disease (CVD) risk was classified as high and low, based on pre-existing diseases, including history of coronary, cerebral, or peripheral artery disease; heart failure; atrial fibrillation; diabetes mellitus; or chronic kidney disease.
RESULTS: Thirty-seven cohort studies were included in this meta-analysis. The pooled hazard ratio for subjects with overt hyperthyroidism compared with the control group was 1.11 (95% confidence interval [CI], 1.03 to 1.19) for IHD, 1.35 (95% CI, 1.03 to 1.75) for stroke, and 1.20 (95% CI, 1.00 to 1.46) for cardiovascular mortality. For subjects with subclinical hyperthyroidism, the pooled hazard ratio was 1.24 (95% CI, 1.07 to 1.45) for IHD, when compared with the control group. Subgroup analysis by CVD risk showed that the risk of stroke in overt hyperthyroidism was increased in the low CVD risk group; however, these association was not observed in the high CVD risk group. Similarly, the risk of IHD in subjects with subclinical hyperthyroidism was significantly increased in the low CVD risk group.
CONCLUSION: Overt hyperthyroidism is associated with increased risk of IHD, stroke, and cardiovascular mortality, and subclinical hyperthyroidism is associated with increased risk of IHD. These associations were particularly observed in the low risk CVD group without underlying CVD.

Entities:  

Keywords:  Heart failure; Hyperthyroidism; Meta-analysis; Mortality; Myocardial infarction; Stroke

Year:  2020        PMID: 33238332     DOI: 10.3803/EnM.2020.728

Source DB:  PubMed          Journal:  Endocrinol Metab (Seoul)        ISSN: 2093-596X


  6 in total

1.  Association of Mild Thyroid Dysfunction and Adverse Prognosis Among Chinese Patients With Acute ST Segment Elevation Myocardial Infarction.

Authors:  Mei-Fang Li; Ze-Tao Wei; Shuai Li; Qi-Ming Feng; Jing-Bo Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

2.  Yearly Incidence of Stroke and Bleeding in Atrial Fibrillation with Concomitant Hyperthyroidism: A National Discharge Database Study.

Authors:  Juqian Zhang; Arnaud Bisson; Grégoire Fauchier; Alexandre Bodin; Julien Herbert; Pierre Henri Ducluzeau; Gregory Y H Lip; Laurent Fauchier
Journal:  J Clin Med       Date:  2022-02-28       Impact factor: 4.241

3.  Weight Gain and Body Composition Changes during the Transition of Thyroid Function in Patients with Graves' Disease Undergoing Radioiodine Treatment.

Authors:  Zhenqin Cai; Qiyu Chen; Yan Ling
Journal:  Int J Endocrinol       Date:  2022-07-18       Impact factor: 2.803

Review 4.  Minor perturbations of thyroid homeostasis and major cardiovascular endpoints-Physiological mechanisms and clinical evidence.

Authors:  Patrick Müller; Melvin Khee-Shing Leow; Johannes W Dietrich
Journal:  Front Cardiovasc Med       Date:  2022-08-15

Review 5.  Thyroid and heart, a clinically relevant relationship.

Authors:  G Corona; L Croce; C Sparano; L Petrone; A Sforza; M Maggi; L Chiovato; M Rotondi
Journal:  J Endocrinol Invest       Date:  2021-05-25       Impact factor: 4.256

6.  Antithyroid Drug Treatment in Graves' Disease.

Authors:  Jae Hoon Chung
Journal:  Endocrinol Metab (Seoul)       Date:  2021-06-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.